Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,432.00    -44.00 (-2.98%)
Bid:
1,430.00
Ask:
1,436.00
Spread: 6.00 (0.42%)
Market Cap: £490.28m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

16 Nov 2023 07:00

RNS Number : 6203T
Craneware plc
16 November 2023
 

 

16 November 2023

 

Craneware plc

?

("Craneware" or the "Company" or the "Group")

 

AGM Statement

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting, which takes place at 10am today.  

 

The Group has enjoyed continued positive financial and operational performance since the start of the new financial year. The partner opportunities which launched at the end of the last financial year continue to gather momentum and the underlying sales pipeline continues to build, converting at an encouraging rate into revenue. With financial results tracking in line with management expectations, we look forward to providing a greater level of detail with our next Trading Update, ahead of our Interim Results.

 

US hospitals are now returning their attention to providing Value-Based Care and building resilience into their operating models through greater insights into their financials and operations. Through Trisus, our cloud-based data analytics and intelligence platform, we plan to be a central player in the digitalisation, the use of data to provide insights that improve the processes, of US healthcare. The team is focused on capturing this opportunity through market expansion and the delivery of increased value to our extensive hospital customer base.

 

We are confident that our resilient business model, extensive customer base, high levels of Annual Recurring Revenue, together with our strategy for delivering growth centred on the expansion of the Trisus platform, will enable us to create further long-term value for all our stakeholders.   

 

For further information, please contact:

 

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

  

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDBBDBCXBDGXU
Date   Source Headline
20th May 202511:27 amRNSForm 8.5 (EPT/NON-RI)-Craneware plc
20th May 202511:09 amRNSForm 8.5 (EPT/RI)-Craneware plc
20th May 20259:59 amRNSForm 8.5 (EPT/RI) - Craneware PLC
20th May 20259:29 amRNSForm 8.3 - Craneware PLC
19th May 20254:23 pmRNSForm 8.5 (EPT/NON-RI)-Craneware plc
19th May 20254:02 pmRNSForm 8.3 - Craneware plc
19th May 20253:20 pmRNSForm 8.3 - Craneware plc
19th May 20253:16 pmRNSForm 8.3 - CRANEWARE PLC
19th May 20252:29 pmGNWForm 8.3 - Craneware Plc
19th May 20252:08 pmBUSForm 8.3 - Craneware PLC
19th May 20251:45 pmGNWForm 8.3 - Craneware plc - Octopus Investments
19th May 20251:43 pmRNSForm 8.3 - Craneware Plc
19th May 20251:42 pmGNWForm 8.3 - [CRANEWARE PLC - 16 05 2025] - (CGAML)
19th May 20251:38 pmGNWForm 8.3 - [CRANEWARE PLC - 16 05 2025] - (CGWL)
19th May 202512:50 pmRNSForm 8.3 - Craneware PLC
19th May 202512:11 pmBUSForm 8.3 - Craneware plc
19th May 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc
19th May 202511:55 amRNSForm 8.3 - Craneware plc
19th May 202511:15 amRNSForm 8.5 (EPT/RI)-Craneware plc
19th May 202511:09 amRNSForm 8.5 (EPT/RI) - CRANEWARE PLC
19th May 202510:31 amRNSForm 8.5 (EPT/RI) - Craneware plc
19th May 20258:57 amGNWForm 8.5 (EPT/RI)-Craneware plc
16th May 20253:16 pmRNSResponse to Statement by Bain Capital
16th May 20251:16 pmRNSForm 8.3 - CRANEWARE PLC
16th May 20259:41 amRNSStatement re Possible Offer
1st May 20253:52 pmRNSHolding(s) in Company
28th Apr 20257:00 amRNSPurchase of Shares by Director and TVR
15th Apr 20257:00 amRNSBlock listing Interim Review
21st Mar 20251:50 pmRNSDividend Currency Election
11th Mar 20257:00 amRNSFY25 Interim Results
19th Feb 20253:23 pmRNSNotification of major holdings
13th Jan 20257:00 amRNSH1 FY25 Trading Update
29th Nov 20244:18 pmRNSDividend Currency Election
20th Nov 20241:57 pmRNSHolding(s) in Company
19th Nov 20245:13 pmRNSVesting of Long Term Incentive Plan Awards and TVR
13th Nov 20241:23 pmRNSResult of AGM
13th Nov 20247:00 amRNSAGM Statement and Board Changes
25th Oct 20243:02 pmRNSHolding(s) in Company
16th Oct 20245:05 pmRNSPosting of Annual Report and Notice of AGM
15th Oct 20247:00 amRNSBlock listing Interim Review
2nd Oct 202412:30 pmRNSTotal Voting Rights
23rd Sep 20245:31 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSExercise of Share Options
17th Sep 20244:40 pmRNSGrant of Long Term Incentive Plan Awards
12th Sep 20244:50 pmRNSNotification of Major Holdings
11th Sep 20243:45 pmRNSDirector/PDMR Dealings
10th Sep 20247:00 amRNSRelease and discharge of security in the Company
3rd Sep 20247:00 amRNSFY24 Final Results
27th Aug 20247:00 amRNSNotice of Results Presentations
18th Jul 20247:00 amRNSFY24 Trading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.